Advances in radiology and pathology of prostate cancer: a review for the pathologist
Pathologica · 2024-02 · 116 (1) · 1-12
DOI: 10.32074/1591-951x-925 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathologica, 2024-02. Verfasst von Pietro Pepe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Urology Unit, Cannizzaro Hospital, Catania, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Multiparametric magnetic resonance imaging (mpMRI) has improved systematic prostate biopsy procedures in the diagnosis of clinically significant prostate cancer (csPCa) by reducing the number of unnecessary biopsies; numerous level one evidence studies have confirmed the accuracy of MRI-targeted biopsy, but, still today, systematic prostate biopsy is recommended to reduce the 15-20% false negative rate of mpMRI. New advanced imaging has been proposed to detect suspicious lesions and perform targeted biopsies especially when mpMRI cannot be performed. Transrectal ultrasound (TRUS) modalities are emerging as methods with greater sensitivity and specificity for the detection of PCa compared to the traditional TRUS; these techniques include elastography and contrast-enhanced ultrasound, as well as improved B-mode and Doppler techniques. These modalities can be combined to define a novel ultrasound approach: multiparametric ultrasound (mpUS). More recently, micro-ultrasound (MicroUS) and prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) have demonstrated to be sensitive for the detection of primary prostatic lesions resulting highly correlated with the aggressiveness of the primary prostatic tumor. In parallel, artificial intelligence is advancing and is set out to deeply change both radiology and pathology. In this study we address the role, advantages and shortcomings of novel imaging techniques for Pca, and discuss future directions including the applications of artificial intelligence–based techniques to imaging as well as histology. The significance of these findings for the practicing pathologist is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Unit, Cannizzaro Hospital, Catania, Italy.
- Urology Unit, Casa di Cura Rizzola San Donà di Piave (VE), Italy.
- Urology Unit, Giovanni Paolo II Hospital, Sciacca, Italy.
- Urology Unit, Santa Maria Hospital-GVM, Bari, Italy.
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.
- Pathology Unit, Ruggi University Hospital, Salerno, Italy.
Zitieren
APA
Pepe, P., Fandella, A., Barbera, M., Martino, P., Merolla, F., Caputo, A., & Fraggetta, F. (2024). Advances in radiology and pathology of prostate cancer: a review for the pathologist. Pathologica, 116(1), 1-12. https://doi.org/10.32074/1591-951x-925
Vancouver
Pepe P, Fandella A, Barbera M, Martino P, Merolla F, Caputo A, et al. Advances in radiology and pathology of prostate cancer: a review for the pathologist. Pathologica. 2024;116(1):1-12. doi:10.32074/1591-951x-925
BibTeX
@article{Pepe2024,
author = {Pepe, Pietro and Fandella, Andrea and Barbera, Michele and Martino, Pasquale and Merolla, Francesco and Caputo, Alessandro and Fraggetta, Filippo},
title = {Advances in radiology and pathology of prostate cancer: a review for the pathologist},
journal = {Pathologica},
year = {2024},
volume = {116},
number = {1},
pages = {1--12},
doi = {10.32074/1591-951x-925}
}
EUVIMED